CTOs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Orbus Therapeutics raised $18M on 08/21/2015

Similar Companies

ClaimSecure Inc

ClaimSecure Inc is a Sudbury, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Veritas Health

Veritas Health is a Deerfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wellness International Network

Wellness International Network is a Plano, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

INFOHEALTH Management

INFOHEALTH Management Corp. is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GTESS Corporation

GTESS Corporation is a Richardson, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.